Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2796 | 2021 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 1484 | 2021 |
Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1457 | 2020 |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1354 | 2021 |
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 502 | 2021 |
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion D Peppa, US Gill, G Reynolds, NJW Easom, LJ Pallett, A Schurich, ... Journal of Experimental Medicine 210 (1), 99-114, 2013 | 367 | 2013 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group, PW Horby, M Mafham, L Peto, M Campbell, G Pessoa-Amorim, ... MedRxiv, 2021.06. 15.21258542, 2021 | 327* | 2021 |
IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection LJ Pallett, J Davies, EJ Colbeck, F Robertson, N Hansi, NJW Easom, ... Journal of Experimental Medicine 214 (6), 1567-1580, 2017 | 325 | 2017 |
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 320 | 2021 |
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 304 | 2022 |
Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission PJ Lillie, A Samson, A Li, K Adams, R Capstick, GD Barlow, N Easom, ... Journal of Infection 80 (5), 578-606, 2020 | 243 | 2020 |
Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D L Bacon, RA Eagle, M Meyer, N Easom, NT Young, J Trowsdale The Journal of Immunology 173 (2), 1078-1084, 2004 | 229 | 2004 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 227 | 2022 |
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 111 | 2021 |
Lessons for managing high-consequence infections from first COVID-19 cases in the UK P Moss, G Barlow, N Easom, P Lillie, A Samson The Lancet 395 (10227), e46, 2020 | 100 | 2020 |
IL-15 overcomes hepatocellular carcinoma-induced NK cell dysfunction NJW Easom, KA Stegmann, L Swadling, LJ Pallett, AR Burton, D Odera, ... Frontiers in immunology 9, 1009, 2018 | 89 | 2018 |
Physical, cognitive and mental health impacts of COVID-19 following hospitalisation–a multi-centre prospective cohort study PHOSP-COVID Collaborative Group, RA Evans, H McAuley, EM Harrison, ... MedRxiv, 2021.03. 22.21254057, 2021 | 82 | 2021 |
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 71 | 2023 |
Sixty‐eight consecutive patients assessed for COVID‐19 infection: experience from a UK regional infectious diseases unit N Easom, P Moss, G Barlow, A Samson, T Taynton, K Adams, M Ivan, ... Influenza and other respiratory viruses 14 (4), 374-379, 2020 | 70 | 2020 |
T cells infiltrating diseased liver express ligands for the NKG2D stress surveillance system WC Huang, NJ Easom, XZ Tang, US Gill, H Singh, F Robertson, C Chang, ... The Journal of Immunology 198 (3), 1172-1182, 2017 | 44 | 2017 |